Global Cancer Research Institute Market
Published Date:Dec 2025
Industry: Healthcare
Regions:
North America,
Europe,
Asia-Pacific,
Latin America,
Middle East & Africa
Format: PDF
Page: 200
Forecast Period: 2025-2033
Historical Range: 2020-2024
Global Cancer Research
Institute Market Segmentation, By Research Focus Area (Basic &
Translational Research, Clinical Research, Prevention & Epidemiology
Research, Precision & Personalized Medicine), By Cancer Type (Solid Tumors
{Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer}, Hematological
Cancers {Leukemia, Lymphoma, Multiple Myeloma}), By Service Type (Research
& Development, Clinical Trial Management, Biomarker Discovery &
Validation, Genomic & Molecular Profiling, Consulting & Advisory
Services), By End-User (Pharmaceutical & Biotechnology Companies, Academic
& Research Institutions, Hospitals & Diagnostic Centers)- Industry
Trends and Forecast to 2033
Global Cancer Research Institute
Market size was valued at USD 76415.3 million
in 2024 and is
expected to reach at USD 169842.8 million in 2033, with a CAGR of 8.9% during
the forecast period of 2025 to 2033.
Global Cancer Research Institute Market Overview
The Global Cancer Research
Institute Market is witnessing steady growth driven by the increasing global
cancer burden and rising investments in oncology research. Institutes worldwide
are focusing on advancing genomics, molecular biology, and immuno-oncology to
develop personalized and targeted treatments. Government funding, public private
collaborations, and technological integration such as artificial intelligence
(AI), bioinformatics, and big data analytics are accelerating breakthroughs in
cancer diagnosis and therapy development. Furthermore, the growing adoption of
precision medicine and early detection programs is fueling research activities.
However, high R&D costs and complex regulatory procedures remain key
challenges to market expansion.
Global Cancer Research Institute Market Scope
|
Global Cancer
Research Institute Market |
|||
|
Years
Considered |
|||
|
Historical Period |
2020 - 2023 |
Market Size (2024) |
USD 76415.3 Million |
|
Base Year |
2024 |
Market Size
(2033) |
USD 169842.8 Million |
|
Forecast Period |
2025 - 2033 |
CAGR (2025 – 2033) |
8.9% |
|
Segments
Covered |
|||
|
By Research Focus Area |
·
Basic & Translational Research ·
Clinical Research ·
Prevention & Epidemiology Research ·
Precision & Personalized Medicine |
||
|
By Cancer Type |
·
Solid
Tumors o Lung Cancer o Breast Cancer o Colorectal Cancer o Prostate Cancer ·
Haematological
Cancers o Leukemia o Lymphoma o Multiple Myeloma |
||
|
By Service Type |
·
Research & Development ·
Clinical Trial Management ·
Biomarker Discovery & Validation ·
Genomic & Molecular Profiling ·
Consulting & Advisory Services |
||
|
By End Users |
·
Pharmaceutical
& Biotechnology Companies ·
Academic
& Research Institutions ·
Hospitals
& Diagnostic Centers ·
Contract
Research Organizations (CROs) |
||
|
Countries Catered |
|||
|
North America |
·
United
States ·
Canada ·
Mexico |
||
|
Europe |
·
United Kingdom ·
Germany ·
France ·
Spain ·
Italy ·
Rest of Europe |
||
|
Asia Pacific |
·
China ·
India ·
Japan ·
Australia ·
South
Korea ·
Rest
of Asia Pacific |
||
|
Latin America |
·
Brazil ·
Argentina ·
Rest of Latin America |
||
|
Middle East
& Africa
|
·
Saudi
Arabia ·
South
Africa ·
Rest
of MEA |
||
|
Key Companies |
|||
|
·
National
Cancer Centre Singapore ·
Dana-Farber Cancer Institute ·
NCI |
|||
Global Cancer Research Institute Market Dynamics
The Global Cancer Research
Institute Market dynamics are shaped by rising cancer incidence, technological
advancements, and growing funding from both public and private sectors.
Increasing demand for precision medicine and early detection tools is driving
innovation in genomics, molecular diagnostics, and immunotherapy research.
Governments and organizations such as the National Cancer Institute (NCI) and
Cancer Research UK are heavily investing in translational and clinical oncology
programs to enhance patient outcomes. The market is also influenced by growing
collaborations between pharmaceutical companies, academic institutions, and
biotech firms, accelerating the development of advanced cancer therapies and
biomarkers.
Technological integration,
including artificial intelligence (AI), machine learning, and bioinformatics,
is revolutionizing cancer research by enabling faster data analysis and
predictive modeling of tumor behavior. However, the market faces challenges such
as high R&D costs, lengthy clinical trial processes, and ethical concerns
related to genetic manipulation and patient data privacy. Furthermore,
disparities in research infrastructure and limited access to advanced
facilities in developing regions hinder global progress. Despite these
restraints, the growing focus on personalized medicine, liquid biopsies, and
gene-based therapies presents lucrative opportunities for expansion. Overall,
the market continues to evolve as institutions strive to translate cutting-edge
research into effective, accessible, and affordable cancer treatments worldwide.
Global Cancer Research
Institute Market Segment Analysis
The Global Cancer Research
Institute Market segment analysis highlights the industry’s multifaceted
structure driven by diverse research priorities, cancer types, service
offerings, and end-user demand. Based on research focus area, the market is
segmented into basic & translational research, clinical research,
prevention & epidemiology research, and precision & personalized
medicine. Basic and translational research dominates the segment, focusing on
understanding tumor biology, gene expression, and molecular mechanisms to
bridge laboratory discoveries with clinical applications. Precision medicine is
growing rapidly due to advancements in genomics and targeted therapy
development.
By cancer type, the market is
categorized into solid tumors—including lung, breast, colorectal, and prostate
cancers—and hematological cancers, such as leukemia, lymphoma, and multiple
myeloma. Solid tumors account for a significant share due to their higher
global prevalence and ongoing initiatives to improve diagnostic imaging and
therapeutic precision. Meanwhile, hematological cancer research is advancing with
innovations in immunotherapies, such as CAR-T and stem cell-based treatments.
Based on service type, the market
includes research & development, clinical trial management, biomarker
discovery & validation, genomic & molecular profiling, and consulting
& advisory services. Research and development form the backbone of the
market, while genomic and biomarker-based profiling are rapidly expanding owing
to the growing role of personalized oncology.
By end-user, the market is
segmented into pharmaceutical & biotechnology companies, academic &
research institutions, and hospitals & diagnostic centers. Pharmaceutical
and biotech firms lead the segment, leveraging cancer research collaborations
for drug discovery and clinical trials. Academic institutions contribute
substantially through basic and translational studies, while hospitals
increasingly participate in clinical research and data-driven cancer care.
Overall, the segmental landscape reflects a dynamic interplay of innovation,
multidisciplinary collaboration, and data-driven approaches transforming global
cancer research.
Global Cancer Research
Institute Market Regional Analysis
The Global Cancer Research
Institute Market regional analysis reveals strong geographic diversification
driven by funding availability, research infrastructure, and healthcare
advancements. North America dominates the market due to the presence of leading
institutes such as the National Cancer Institute (NCI) and major pharmaceutical
players investing heavily in oncology research and precision medicine. Europe
follows closely, with countries like the U.K., Germany, and France emphasizing
translational research, genomics, and clinical trial collaborations under
initiatives such as Horizon Europe. The Asia-Pacific region is experiencing
rapid growth, fueled by rising cancer prevalence, expanding biotechnology
sectors, and increased government support for cancer research in China, Japan,
South Korea, and India. Latin America and the Middle East & Africa are
emerging markets, gradually improving research infrastructure and fostering
partnerships with global organizations. Overall, the market’s regional landscape
is shaped by a mix of mature research ecosystems and emerging innovation hubs
driving oncology advancements worldwide.
Global Cancer Research Institute Market Key Players
·
National Cancer Centre Singapore
·
Tata Memorial
·
Karolinska Institute
·
Dana-Farber Cancer Institute
·
MD Anderson
·
Memorial Sloan Kettering
·
Fred Hutchinson
·
NCI
·
Mayo Clinic
·
Roswell Park
Recent Developments
In September 24, 2024, Cancer
Research Institute (CRI) teamed up with the Kidney Cancer Association
(KCA), to co-fund a targeted immunotherapy research grant under CRI’s CLIP
programme, focused on kidney cancer.
In June 17, 2025, CRI
also entered into a new collaboration with OCCAM Immune at Mount Sinai, to
monitor immune-system responses in cancer clinical trials, enhancing precision
immunotherapy efforts.
Research Methodology
At Foreclaro Global Research, our
research methodology is firmly rooted in a comprehensive and systematic
approach to market research. We leverage a blend of reliable public and
proprietary data sources, including industry reports, government publications,
company filings, trade journals, investor presentations, and credible online
databases. Our analysts critically evaluate and triangulate information to
ensure accuracy, consistency, and depth of insights. We follow a top-down and
bottom-up data modelling framework to estimate market sizes and forecasts,
supplemented by competitive benchmarking and trend analysis. Each research
output is tailored to client needs, backed by transparent data validation
practices, and continuously refined to reflect dynamic market conditions.
Table of Contents
Chapter 1. Introduction
1.1. Report Description
1.2. Key Market Segments
1.3. Regulatory Scenario
1.4. Executive Summary
Chapter 2. Research Methodology
2.1. Secondary Research
2.2. Primary Research
2.3. Secondary Analyst Tools and Models
Chapter 3. Market Dynamics
3.1. Market
driver analysis
3.1.1. Rising
global cancer prevalence driving demand for advanced research and therapeutic
innovations
3.1.2. Increasing
government and private funding for oncology R&D programs
3.2. Market
restraint analysis
3.2.1. High
cost of oncology research, drug development, and clinical trials
3.3. Market
Opportunity
3.3.1. Expansion
of public–private partnerships to accelerate translational cancer research
3.4. Market
Challenges
3.4.1. Limited
access to high-quality biological samples and genomic data
Chapter 4. Market Variables and Outlook
4.1. SWOT
Analysis
4.1.1. Strengths
4.1.2. Weaknesses
4.1.3. Opportunities
4.1.4. Threats
4.2. PESTEL
Analysis
4.2.1. Political
Landscape
4.2.2. Economic Landscape
4.2.3. Social
Landscape
4.2.4. Technological
Landscape
4.2.5. Environmental
Landscape
4.2.6. Legal
Landscape
4.3. Porter’s
Five Forces Analysis
4.3.1. Bargaining
Power of Suppliers
4.3.2. Bargaining
Power of Buyers
4.3.3. Threat
of Substitute
4.3.4. Threat
of New Entrant
4.3.5. Competitive
Rivalry
4.4. Value
Chain Analysis
4.5. Covid
Impact Analysis
Chapter 5. Cancer Research Institute Market: Research
Focus Area Estimates & Trend Analysis
5.1. Cancer
Research Institute Market value share and forecast, (2020 to 2033)
5.2. Incremental
Growth Analysis and Infographic Presentation
5.3. Basic
& Translational Research
5.4. Clinical
Research
5.5. Prevention
& Epidemiology Research
5.6. Precision
& Personalized Medicine
Chapter 6. Cancer Research Institute Market: Cancer
Type Estimates & Trend Analysis
6.1. Cancer
Research Institute Market value share and forecast, (2020 to 2033)
6.2. Incremental
Growth Analysis and Infographic Presentation
6.3. Solid
Tumors
6.3.1. Lung
Cancer
6.3.2. Breast
Cancer
6.3.3. Colorectal
Cancer
6.3.4. Prostate
Cancer
6.3.5. Hematological
Cancers
6.3.6. Leukemia
6.3.7. Lymphoma
6.3.8. Multiple
Myeloma
Chapter 7. Cancer Research Institute Market: Service
Type Estimates & Trend Analysis
7.1. Cancer
Research Institute Market value share and forecast, (2020 to 2033)
7.2. Incremental
Growth Analysis and Infographic Presentation
7.3. Research
& Development
7.4. Clinical
Trial Management
7.5. Biomarker
Discovery & Validation
7.6. Genomic
& Molecular Profiling
7.7. Consulting
& Advisory Services
Chapter 8. Cancer Research Institute Market: End User Estimates
& Trend Analysis
8.1. Cancer
Research Institute Market value share and forecast, (2020 to 2033)
8.2. Incremental
Growth Analysis and Infographic Presentation
8.3. Pharmaceutical
& Biotechnology Companies
8.4. Academic
& Research Institutions
8.5. Hospitals
& Diagnostic Centers
8.6. Contract
Research Organizations (CROs)
Chapter 9. Cancer Research Institute Market: Regional
Estimates & Trend Analysis
9.1. Cancer
Research Institute Market value share and forecast, (2020 to 2033)
9.2. Incremental
Growth Analysis and Infographic Presentation
9.3. North
America
9.4. Europe
9.5. Asia
Pacific
9.6. Middle
East & Africa
9.7. Latin
America
Chapter 10. Cancer Research Institute Market: Country
Estimates & Trend Analysis
10.1. Cancer
Research Institute Market value share and forecast, (2020 to 2033)
10.2. Incremental
Growth Analysis and Infographic Presentation
10.3. United
States
10.4. Canada
10.5. Mexico
10.6. United
Kingdom
10.7. France
10.8. Germany
10.9. Italy
10.10. Spain
10.11. China
10.12. India
10.13. Japan
10.14. South
Korea
10.15. Australia
10.16. Brazil
10.17. Argentina
10.18. Saudi
Arabia
10.19. South
Africa
Chapter 11. Competitive Landscape
11.1. Company
Market Share Analysis
11.2. Vendor
Landscape
11.3. Competition
Dashboard
Chapter 12. Company Profiles
12.1. National
Cancer Centre Singapore
12.1.1. Company
Overview
12.1.2. Financial
Details
12.1.3. Product
Analysis
12.1.4. Recent
Developments
12.2. Tata
Memorial
12.2.1. Company
Overview
12.2.2. Financial
Details
12.2.3. Product
Analysis
12.2.4. Recent
Developments
12.3. Karolinska
Institute
12.3.1. Company
Overview
12.3.2. Financial
Details
12.3.3. Product
Analysis
12.3.4. Recent
Developments
12.4. Dana-Farber
Cancer Institute
12.4.1. Company
Overview
12.4.2. Financial
Details
12.4.3. Product
Analysis
12.4.4. Recent
Developments
12.5. MD
Anderson
12.5.1. Company
Overview
12.5.2. Financial
Details
12.5.3. Product
Analysis
12.5.4. Recent
Developments
12.6. Memorial
Sloan Kettering
12.6.1. Company
Overview
12.6.2. Financial
Details
12.6.3. Product
Analysis
12.6.4. Recent
Developments
12.7. Fred
Hutchinson
12.7.1. Company
Overview
12.7.2. Financial
Details
12.7.3. Product
Analysis
12.7.4. Recent
Developments
12.8. NCI
12.8.1. Company
Overview
12.8.2. Financial
Details
12.8.3. Product
Analysis
12.8.4. Recent
Developments
12.9. Mayo
Clinic
12.9.1. Company
Overview
12.9.2. Financial
Details
12.9.3. Product
Analysis
12.9.4. Recent
Developments
12.10. Roswell
Park
12.10.1.
Company Overview
12.10.2.
Financial Details
12.10.3.
Product Analysis
12.10.4. Recent Developments
Segmentation
Cancer
Research Institute Market, Cancer Type Outlook (Revenue - USD Million, 2020 -
2033)
Solid
Tumors
·
Lung
Cancer
·
Breast
Cancer
·
Colorectal
Cancer
·
Prostate
Cancer
Hematological
Cancers
·
Leukemia
·
Lymphoma
·
Multiple
Myeloma
Cancer
Research Institute Market, Service Type Outlook (Revenue - USD Million, 2020 -
2033)
Research
& Development
Clinical
Trial Management
Biomarker
Discovery & Validation
Genomic
& Molecular Profiling
Consulting
& Advisory Services
Cancer
Research Institute Market, End User Outlook (Revenue - USD Million, 2020 -
2033)
Pharmaceutical
& Biotechnology Companies
Academic
& Research Institutions
Hospitals
& Diagnostic Centers
Contract
Research Organizations (CROs)
Cancer
Research Institute Market, Regional Outlook (Revenue - USD Million, 2020 -
2033)
North
America
Europe
Asia
Pacific
Latin
America
Middle East
& Africa
Methodology
Review our research methodology and quality standards for details about source selection, validation, forecasting, and review.
At Foreclaro Global Research, our research methodology is built to deliver clear, data-backed intelligence that supports confident decision-making. By combining rigorous secondary research, primary validations, and advanced forecasting models, we produce insights that are not only reliable but also strategically relevant for our clients.
1. Defining the Research Framework
Every study begins with a clear understanding of our client’s goals. We establish the market scope, define critical variables, and build a research framework tailored to the specific project. This upfront clarity ensures that our findings are sharply aligned with the strategic questions being addressed.
2. Robust Data Collection
Our analysts extract high-integrity data from a broad mix of credible sources including government databases, annual reports, regulatory filings, trade publications, scientific journals, and trusted industry portals. This secondary research is then supported with targeted primary inputs through interviews with key industry stakeholders—such as executives, subject matter experts, and channel partners—to capture real-world insights and contextual depth.
3. Advanced Forecasting and Modeling
To estimate market size and growth, we employ a hybrid of top-down and bottom-up modeling techniques. Our analysts apply proven forecasting models using historical data trends, economic indicators, technology adoption rates, and demand patterns. Sensitivity analysis and scenario modeling (base, optimistic, conservative) are incorporated to account for market volatility and uncertainty.
4. Data Triangulation and Validation
Accuracy is non-negotiable. We cross-validate every data point by triangulating it across three dimensions: source credibility, numerical consistency, and contextual alignment. This ensures our insights are not just statistically correct but strategically dependable. Discrepancies are resolved using subject expertise and multi-perspective reviews to deliver a balanced, unbiased analysis.
5. Quality Assurance and Final Review
Before delivery, each report undergoes a stringent quality assurance process. Our research output is reviewed for structure, clarity, consistency, and compliance with global standards. The final deliverable is tailored for decision-makers, whether it's a comprehensive industry report, data dashboard, or strategic presentation.
Why Our Methodology Works
What sets us apart is our adaptive data architecture and our commitment to analytical clarity. Every study is built with flexibility to accommodate dynamic markets, while our team blends quantitative rigor with domain-specific expertise. This allows us to deliver research that goes beyond information, we deliver intelligence that leads to action.
Support Questions
What is the market size and growth forecast for the Cancer Research Institute market??
In 2024 the global Cancer Research Institute market size was valued at USD 76,415.3 million. And the market is expected to grow to USD 169,842.8 million by 2033, representing a CAGR of 8.9% from 2025 to 2033.
What key segments does the market cover (for segmentation)??
What are the major drivers behind growth in the Cancer Research Institute market??
What are the main challenges or restraints to market growth??
Which geographic regions and end-users dominate the market according to the report??
Related Reports
-
Healthcare Forecast: 2026-2033
Menopause Market Outlook, Growth & CAGR
Global Menopause Market Segmentation, By Treatment Type (Hormone Replacement Therapy (HRT), Non-Hormonal Therapy, Dietary Supplements & Nutraceuti...
-
Healthcare Forecast: 2026-2033
Occupational Rehabilitation Market Report Forecast
Global Occupational Rehabilitation Market Segmentation, By Service Type (Physical Therapy, Occupational Therapy, Vocational Rehabilitation, Ergonomic...
-
Healthcare Forecast: 2026-2033
Global Hospital-at-Home (HaH) Technology Market
Global Hospital-at-Home (HaH) Technology Market Segmentation, By Technology Type (Remote Patient Monitoring Systems, Telehealth & Virtual Care Pla...
-
Healthcare Forecast: 2026-2033
Global Clinical Intelligence Market
Global Clinical Intelligence Market Segmentation, By Application (Clinical Decision Support, Patient Management, Data Analytics, Workflow Optimizati...